UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 233

Sortiert nach

Pharmacogenetics: From Bench to Byte- An Update of Guidelines

Clinical pharmacology and therapeutics, 2011-05, Vol.89 (5), p.662-673

2011

Link zum Volltext

Verfügbarkeit prüfen

A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using LC-MS/MS

Talanta (Oxford), 2015-03, Vol.134, p.165-172

2015

Link zum Volltext

Verfügbarkeit prüfen

Relation between CYP2D6 Genotype, Phenotype and Therapeutic Drug Concentrations among Nortriptyline and Venlafaxine Users in Old Age Psychiatry

Pharmacopsychiatry, 2016-09, Vol.49 (5), p.186

2016

Link zum Volltext

Verfügbarkeit prüfen

Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review

Diabetic medicine, 2015-07, Vol.32 (7), p.853-864

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics: From Bench to Byte

Clinical pharmacology and therapeutics, 2008-05, Vol.83 (5), p.781-787

2008

Link zum Volltext

Verfügbarkeit prüfen

Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS

Analytical and bioanalytical chemistry, 2014-04, Vol.406 (9-10), p.2349-2353

2014

Link zum Volltext

Verfügbarkeit prüfen

Gene polymorphism of serotonin receptors and drug-induced hyperprolactinemia in schizophrenic patients

European neuropsychopharmacology, 2016-10, Vol.26, p.S515-S516

2016

Link zum Volltext

Verfügbarkeit prüfen

CYP2D6 and catechol-O-methyltransferase gene polymorphisms in Parkinson patients with levodopa-induced dyskinesias

European neuropsychopharmacology, 2016-10, Vol.26, p.S656-S657

2016

Link zum Volltext

Verfügbarkeit prüfen

Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

The pharmacogenomics journal, 2012-02, Vol.12 (1), p.62-67

2012

Link zum Volltext

Verfügbarkeit prüfen

P.5.d.005 Polymorphisms of DRD2, DRD3, DRD4 and HTR2C genes in levodopa-induced dyskinesias in Parkinson's disease

European neuropsychopharmacology, 2015-09, Vol.25, p.S589-S589

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of clomipramine during pregnancy

European journal of clinical pharmacology, 2015-12, Vol.71 (12), p.1493-1500

2015

Link zum Volltext

Verfügbarkeit prüfen

4-Aminopyridine as a life-saving treatment in calcium channel antagonist intoxication

Netherlands journal of medicine, 2016-07, Vol.74 (6), p.276-276

2016

Link zum Volltext

Verfügbarkeit prüfen

NMDA receptor genotypes associated with the vulnerability to develop dyskinesia

Translational psychiatry, 2012-01, Vol.2 (1), p.e67-e67

2012

Link zum Volltext

Verfügbarkeit prüfen

Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia

Progress in neuro-psychopharmacology & biological psychiatry, 2009-04, Vol.33 (3), p.475-481

2009

Link zum Volltext

Verfügbarkeit prüfen

P.3.a.006 Tardive dyskinesia, dehydroepiandrosterone sulfate and cytochrome P450c17α gene polymorphism in psychiatric inpatients

European neuropsychopharmacology, 2014-10, Vol.24, p.S486-S487

2014

Link zum Volltext

Verfügbarkeit prüfen

Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia

Human psychopharmacology, 2010-01, Vol.25 (1), p.84-91

2010

Link zum Volltext

Verfügbarkeit prüfen

Influencing CYP enzymes to boost psychiatric treatment: a review on clinical evidence

Pharmacopsychiatry, 2013-03, Vol.46 (2), p.43

2013

Link zum Volltext

Verfügbarkeit prüfen

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children

European journal of clinical pharmacology, 2013-03, Vol.69 (3), p.541-547

2013

Link zum Volltext

Verfügbarkeit prüfen

P.583 Polymorphisms in BDNF, AKT1, GSK3B genes: possible association with antipsychotic-induced hyperprolactinemia in schizophrenia patients

European neuropsychopharmacology, 2020-11, Vol.40, p.S331-S332

2020

Link zum Volltext

Verfügbarkeit prüfen

P.0579 Pharmacogenetic study to elucidate putative dopaminergic mechanisms of antidepressant action

European neuropsychopharmacology, 2021-12, Vol.53, p.S424-S425

2021

Link zum Volltext

Verfügbarkeit prüfen

CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers : indications for oral contraceptive-related gender differences

European journal of clinical pharmacology, 1999-05, Vol.55 (3), p.177-184

1999

Link zum Volltext

Verfügbarkeit prüfen

Aconitum sp. alkaloids: the modulation of voltage-dependent Na + channels, toxicity and antinociceptive properties

European journal of pharmacology, 1997-10, Vol.337 (2), p.165-174

1997

Link zum Volltext

Verfügbarkeit prüfen

P.3.001 NMDA receptor co-determines vulnerability to develop dyskinesia in Huntington's Disease and levodopa-induced dyskinesia but not tardive dyskinesia

European neuropsychopharmacology, 2011, Vol.21, p.S142-S142

2011

Link zum Volltext

Verfügbarkeit prüfen

P.3.c.002 Association between the alpha-2a-adrenergic receptor 1291 C/G polymorphism and the metabolic syndrome

European neuropsychopharmacology, 2010, Vol.20, p.S458-S459

2010

Link zum Volltext

Verfügbarkeit prüfen

P.3.c.001 Association between HTR2C polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

European neuropsychopharmacology, 2010, Vol.20, p.S458-S458

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 233

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(206)
Mit Volltextzugriff
(193)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(100)
Life Sciences & Biomedicine
(98)
Animals
(97)
Male
(97)
Rats
(79)
Pharmacology & Pharmacy
(76)
Biological And Medical Sciences
(71)
Medical Sciences
(61)
Pharmacology. Drug Treatments
(58)
Rats, Inbred Strains
(53)
Blood Pressure - Drug Effects
(45)
Humans
(40)
In Vitro Techniques
(35)
Cardiovascular System
(34)
Female
(33)
Adrenergic Alpha-Agonists - Pharmacology
(25)
Vasoconstriction - Drug Effects
(25)
Receptors, Adrenergic, Alpha - Drug Effects
(24)
Dose-Response Relationship, Drug
(23)
Calcium - Metabolism
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacogenetics: From Bench to Byte- An Update of Guidelines

A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using LC-MS/MS

Relation between CYP2D6 Genotype, Phenotype and Therapeutic Drug Concentrations among Nortriptyline and Venlafaxine Users in Old Age Psychiatry

Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review

Pharmacogenetics: From Bench to Byte

Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS

Gene polymorphism of serotonin receptors and drug-induced hyperprolactinemia in schizophrenic patients

CYP2D6 and catechol-O-methyltransferase gene polymorphisms in Parkinson patients with levodopa-induced dyskinesias

Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

P.5.d.005 Polymorphisms of DRD2, DRD3, DRD4 and HTR2C genes in levodopa-induced dyskinesias in Parkinson's disease

Pharmacokinetics of clomipramine during pregnancy

4-Aminopyridine as a life-saving treatment in calcium channel antagonist intoxication

NMDA receptor genotypes associated with the vulnerability to develop dyskinesia

Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia

P.3.a.006 Tardive dyskinesia, dehydroepiandrosterone sulfate and cytochrome P450c17α gene polymorphism in psychiatric inpatients

Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia

Influencing CYP enzymes to boost psychiatric treatment: a review on clinical evidence

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children

P.583 Polymorphisms in BDNF, AKT1, GSK3B genes: possible association with antipsychotic-induced hyperprolactinemia in schizophrenia patients

P.0579 Pharmacogenetic study to elucidate putative dopaminergic mechanisms of antidepressant action

CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers : indications for oral contraceptive-related gender differences

Aconitum sp. alkaloids: the modulation of voltage-dependent Na + channels, toxicity and antinociceptive properties

P.3.001 NMDA receptor co-determines vulnerability to develop dyskinesia in Huntington's Disease and levodopa-induced dyskinesia but not tardive dyskinesia

P.3.c.002 Association between the alpha-2a-adrenergic receptor 1291 C/G polymorphism and the metabolic syndrome

P.3.c.001 Association between HTR2C polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

Suchergebnisse filtern